ReviewJournal of personalized medicine2020

Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature.

Ioana-Ecaterina Pralea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.